Antimicrobial effect of cefixime on 6 species of periodotopathogens
![]() |
Jang, Hyun-Seon
(Dept. of Periodontology, College of Dentistry, Chosun University, Oral Biology Research Institute, Chosun University)
Park, Mun-Gyu (Dept. of Periodontology, College of Dentistry, Chosun University) Kook, Joong-Ki (Dept. of Oral Biochemistry, College of Dentistry, Chosun University, Oral Biology Research Institute, Chosun University) Kim, Hwa-Sook (Dept. of Oral Biochemistry, College of Dentistry, Chosun University) Kim, Byung-Ock (Dept. of Periodontology, College of Dentistry, Chosun University, Oral Biology Research Institute, Chosun University) |
1 | Eick S, Seltmann T, Pfister W. Efficacy of antibiotics to strains of periodonto-pathogenic bacteria within a single species biofilman in vitro study. J Clin Periodontol 2004;31(5):376-383 DOI ScienceOn |
2 | Gordon JM, Walker CB, Goodson JM, Socransky SS. Sensitivity assay for measuring tetracycline levels in gingival crevice fluid. Antimicrob Agents Chemother 1980;17:193-198 DOI PUBMED ScienceOn |
3 | van Winkelhoff, A., Rams, T.E., Slots, J. : Systemic antibiotic therapy in periodontitis. J Periodontol 2000. 1996;10:45-78 DOI ScienceOn |
4 | Lehtonen L, Huovinen P. Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents. Scand J Infect Dis 1993:25(3) :373-378 DOI ScienceOn |
5 | Lavy E, Ziv G, Aroch I, Glickman A. Clinical pharmacologic aspects of cefixime in dogs. Am J Vet Res 1995;6(5):633-638 |
6 | Choi JH, Seong JR, Kook JK, Kim DK. Comparison of cultural method and PCR method for the assay of tetracycline-resistant Fusobacterium nucleatum isolated in Korean. J Kor Acad Dent Health 2003;27(4):581-589 |
7 | Bokor-Bratic M, Brkanic T. Clinical use of tetracyclines in the treatment of periodontal diseases. Med Pregl 2000;53:266-271 PUBMED |
8 | Slot J, Rams TE. Antibiotics in periodontal therapy advantages and disadvantages. J Clin Periodontol 1990;17:479-493 DOI PUBMED |
9 | Olsvik B. Tetracycline resistance in oral microorganisms in patients with periodontal disease. Nor Tannlaegeforen Tid 1991;101(2):50-52 PUBMED |
10 | Tanner A. Kent R. Maiden :MF, Taubman MA. Clinical. microbiological and immunological profile of healthy, gingivitis, and putative active periodontal subjects. J Periodont Res 1996;31:195-204 DOI ScienceOn |
11 | Sigusch B, Beier M. Klinger G, Pfister W, Glockmann E. A 2-step non-surgical procedure and systemic antibiotics in the treatment of rapidly progressive periodontitis. J periodontol 2001;72:275-283 DOI ScienceOn |
12 | Walker, C.B. The acquisition of antibiotic resistance in the periodontal disease. Peridontol 2000. 1996;10:78-88 |
13 | Sirinian G, Shimizu T, Sugar C, Slots J, Chen C. Periodontopathic bacteria in young healthy subjects of different ethnic backgrounds in los angeles. J periodontol 2002;73:283-288 DOI ScienceOn |
14 | Haffaiee AD, Socransky SS, Dibart S, Kent RL. Response to periodontal therapy in patients with high or low levels of P. gingivalis. P. intermedia, P. nigrescens and B. forsythus. J Clin Periodontol 1996;23(4):336-345 DOI PUBMED |
15 | Ali RW, Johannessen AC, Dahlen G, Socransky SS. Skaug N. Comparison of the subgingival microbiota of periodontally healthy and diseased adults in Northern Cameroon. J Clin Periodontol 1997 24;830-835 DOI ScienceOn |
16 | Fuchs PC. Jones RN. Barry AL. et al. In vitro evaluation of cefixime (FK027. FR17027. CL284635): spectrum against recent clinical isolates. comparative antimicrobial activity. beta-lactamase stability. and preliminary susceptibility testing criteria. Diagn Microbiol Infect Dis 1986;5(2):151-62 DOI ScienceOn |
17 | Purucker P, Mertes H Goodson JM. Bernimoulin JP. Local versus systemic adiuctive antibiotic therapy in 28 patients with generalized aggressive periodontitis. J periodontol 2001;72:1241-1245 DOI ScienceOn |
18 | Paster BJ. Boches SK. Galvin JL, Ericson RE. Lau CN. Levanos VA. Sahasrabudhe A. Dewhirst FE. Bacterial diversity in human subgingival plaque. J Bacteriology 2001;12:3770-3783 |
19 | Larsen T, Fiehn NE. Development of resistance to metronidazole and minocycline in vitro. J Clin Periodontol 1997;24(4):254-259 DOI ScienceOn |
20 | 치주과교수협의회.: 치주과학, 4판, 군자출판사, 2004 |
21 | Barry AL. Jones RN. Cefixime: spectrum of antibacterial activity against 16.016 clinical isolates. Pediatr Infect Dis J 1987;6(10):954-947 DOI PUBMED ScienceOn |
22 | Klepser :ME. Marangos MN. Patel KB. et al. Clinical pharmacokinetics of newer cephalosporins. Clin Pharmacokinet. 1995;28(5):361-384 DOI ScienceOn |
23 | Faulkner RD, Yacobi A, Barone JS, Kaplan SA, Silber BM. Pharmacokinetic profile of cefixime in man. Pediatr Infect Dis J 1987;6(10):963-970 DOI PUBMED ScienceOn |
24 | Poulet PP, Duffaut D, Lodter JP. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease. J Clin Periodontol 1999; 26(4): 261-263 DOI ScienceOn |
25 | Murray PR, Jorgensen JR. Quantitative susceptibility test methods in major united states medical center. Antimicrobial agent and chemotherapy 1981;20:66-70 DOI ScienceOn |
26 | Paiukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H. In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomyce-temcomitans. Scand J Dent Res 1993;101(5):299-303 PUBMED |
![]() |